₹575.85
+5.80 (+1.02%)
As of 22 Sept 2026, Coral Laboratories Ltd share price is ₹575.85. The stock opened at ₹575.85 and had closed at ₹570.05 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹360.00 and a high of ₹679.00. In terms of performance, Coral Laboratories Ltd share price has increased by 38.36% over the past six months and has increased by 13.97% over the last year.
Coral Labs. Stock Price Chart
Coral Laboratories Ltd Overview
Market cap₹206 Crs
Volume719
Prev. Close₹570.05
Year range₹360.00 - ₹679.00
ISININE683E01017
About Coral Labs.
Coral Laboratories is engaged in manufacturing of Pharmaceutical formulations.
Coral Laboratories Ltd Historical Performance
1 Month Return-11.42%
6 Month Return38.36%
3 Year Return106.03%
3 Month Return-7.35%
1 Year Return10.67%
5 Year Return40.61%
Coral Laboratories Ltd Fundamentals
ROCE(TTM)10.89%
P/E Ratio (TTM)10.70
P/B Ratio0.98
Debt to Equity0.02
ROE7.83%
EPS (TTM)53.11
Dividend Yield0.35%
Book Value585.75
Profit Margin19.62%
Operating Margin16.72%
Coral Laboratories Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 95.80 | 124.12 | 90.29 | 85.02 | 80.42 |
| EBITDA | 25.43 | 34.58 | 22.71 | 10.75 | 13.99 |
| Net Profit | 16.38 | 24.16 | 15.79 | 6.45 | 9.05 |
| EPS | 45.85 | 67.61 | 44.19 | 18.04 | 25.32 |
Coral Laboratories Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 560.37 |
| Resistance 1 (R1) | 579.37 |
| Pivot Point | 569.68 |
Coral Laboratories Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 22-Sep-2026 | 30-May-2026 | 22-Sep-2026 | Final | ₹2.00 |
| 19-Sep-2025 | 30-May-2025 | 19-Sep-2025 | Final | ₹1.50 |
| 20-Sep-2024 | 12-Jul-2024 | 21-Sep-2024 | Final | ₹2.00 |
Coral Laboratories Ltd Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Girish Dhameja | Whole-time Directorector |
| Sushma Chinchane | Non Executive Director |
| Saurabh Shah | Non Executive Independent Director |
Coral Laboratories Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,868.90+1.72% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,410.50+0.38% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,970.00+2.69% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Coral Laboratories Ltd today is ₹575.85 on NSE and ₹575.85 on BSE.
- The 52-week high of Coral Laboratories Ltd is ₹679.00, while the 52-week low is ₹360.00.
- The current market capitalisation of Coral Laboratories Ltd is approximately ₹206 crore.
- The P/E (Price-to-Earnings) ratio of Coral Laboratories Ltd is 10.70. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Coral Laboratories Ltd is 0.98. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Coral Laboratories Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for Coral Labs. on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Coral Laboratories Ltd has delivered a return of approximately 106.03%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Coral Laboratories Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 71.51% promoters, 0.00% FIIs, 0.00% DIIs, and 19.93% public shareholders.

